# Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children With ADHD: A Randomized, Placebo-Controlled Study

> **NCT06841666** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Tanta University** · enrollment: 100 (estimated)

## Conditions studied

- ADHD
- Primary Nocturnal Enuresis

## Interventions

- **DRUG:** Atomoxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06841666
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-28
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-09-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06841666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06841666, "Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children With ADHD: A Randomized, Placebo-Controlled Study". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06841666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*